108474-85-7Relevant academic research and scientific papers
Palladium nanoparticles supported on triazine functionalised mesoporous covalent organic polymers as efficient catalysts for Mizoroki-Heck cross coupling reaction
Puthiaraj, Pillaiyar,Pitchumani, Kasi
, p. 4223 - 4233 (2014)
A novel class of mesoporous covalent organic polymer (MCOP) was synthesised by the nucleophilic substitution of cyanuric chloride with 4,4′- dihydroxybiphenyl. The MCOP was fully characterized using powder X-ray diffraction analysis, Fourier transform infrared spectroscopy, 13C-solid state NMR spectroscopy, field emission scanning electron microscopy and thermogravimetric analysis. These nitrogen rich materials act as good supports for palladium nanoparticles (Pd NPs) and exhibit excellent catalytic activity towards Mizoroki-Heck cross coupling between aryl bromides and alkenes. Hot filtration tests demonstrate that the presence of the triazine rings on the polymers is beneficial for enhancing the stability of Pd NPs. The polymers are also cheap, easy to synthesise and can be recycled up to five times with only a minor loss of activity. the Partner Organisations 2014.
Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor
Nakao, Syuhei,Mabuchi, Miyuki,Wang, Shenglan,Kogure, Yoko,Shimizu, Tadashi,Noguchi, Koichi,Tanaka, Akito,Dai, Yi
supporting information, p. 3167 - 3172 (2017/06/13)
A series of 31 resveratrol derivatives was designed, synthesized and evaluated for activation and inhibition of the TRPA1 channel. Most acted as activators and desensitizers of TRPA1 channels like resveratrol or allyl isothiocyanate (AITC). Compound 4z (HUHS029) exhibited higher inhibitory activity than resveratrol with an IC50 value of 16.1?μM. The activity of 4z on TRPA1 was confirmed in TRPA1-expressing HEK293 cells, as well as in rat dorsal root ganglia neurons by a whole cell patch clamp recording. Furthermore, pretreatment with 4z exhibited an analgesic effect on AITC-evoked TRPA1-related pain behavior in vivo.
